Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Ascletis Announces Completion of Enrollment of 120 Patients in the Phase III Clinical Trial of FASN Inhibitor ASC40 Combined with Bevacizumab for Treatment of Recurrent Glioblastoma 2023-09-26 08:10
Recommended Souvenir from Korea, Jung Kwan Jang Red Ginseng 2023-09-26 08:00
Johnson & Johnson Innovation Announces Collaboration with Singapore Economic Development Board to Help Transform Singapore's Life Science Innovation Ecosystem 2023-09-26 06:30
The 88th CMEF in Shenzhen Set to Spotlight Advancements in the Medical Equipment Industry 2023-09-25 21:00
Chime Biologics Enters into a Strategic Cooperation Agreement with Korea Kings Pharm to Accelerate the Biosimilar Launch 2023-09-25 20:15
Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients 2023-09-25 20:00
Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology 2023-09-25 19:00
Xtep Unveils Milestone Brand Strategy Upgrade to Offer World-Class Running Shoes and Gears 2023-09-25 18:48
EQT PRIVATE EQUITY TO SELL LIMACORPORATE TO ENOVIS: THE ITALIAN SITE IN SAN DANIELE DEL FRIULI WILL REMAIN THE FULCRUM OF PRODUCTION, BENEFITING FROM NEW INVESTMENTS 2023-09-25 18:01
Huawei Accelerates Intelligent Healthcare with the Innovative Digital Medical Technology Solution 2023-09-25 15:35
"Kexing Biopharm 2023 Innovation Forum on Targeted Drug Delivery" 2023-09-25 15:31
Pierre Fabre Laboratories and Vernalis announce a drug discovery collaboration in oncology 2023-09-25 15:00
Power Up with Energizer's Re-Energize 100% Fitfest this October 2023-09-25 11:48
'Bayer For Her' Supporting 365 Days Conversations of Care to More Women in Asia 2023-09-25 09:56
ASTRAZENECA AND INSTITUT KANSER NEGARA PARTNER TO INTRODUCE AI TECHNOLOGY FOR LUNG SCREENING 2023-09-25 09:00
AffaMed Therapeutics Announces Clinical Trial Application Approval in Mainland China for Risuteganib (Luminate®) First-in-Class Candidate for the Treatment of Intermediate Dry AMD 2023-09-25 09:00
Henlius' Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ESCC 2023-09-25 07:41
MediLink Therapeutics: Focuses on ADC research and development to promote new prospects for cancer treatment 2023-09-23 18:29
Concord Medical Reports Financial Results for the First Half of 2023 2023-09-23 05:00
Biomerics Announces Completion of 100,000 sq. ft. Expansion of Brooklyn Park, MN, Facility 2023-09-22 22:03
1 102 103 104 105 106 1508